Investigating blood-based markers for Alzheimer's disease risk in veterans
Official title: The epigenetics of dementia risk in the Million Veteran Program
Funded at VA Boston Health Care System · NIH-10918836 · Data updated 2026-11-12
This study is looking at how changes in your blood's DNA can help us figure out if older veterans might be at risk for Alzheimer's and related memory issues, with the hope of creating easy blood tests to catch these problems early and keep track of them better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | VA Boston Health Care System NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| NIH project number | 1I01BX006549-01 |
| Project ID | NIH-10918836 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are veterans aged 65 and older, particularly those with a family history of Alzheimer's disease or related dementias.
✕Less likely to help
Patients under the age of 65 or those without a risk of Alzheimer's disease or related dementias may not benefit from this research.
What this research studies
This research focuses on understanding how changes in DNA methylation in the blood can indicate the risk of Alzheimer's disease and related dementias (ADRD) among veterans aged 65 and older. By analyzing data from the Million Veteran Program, the study aims to identify specific DNA markers that could lead to the development of simple blood tests for diagnosing and monitoring ADRD. The approach is less invasive and more cost-effective compared to current diagnostic methods, which often involve expensive imaging techniques. Ultimately, the goal is to improve early detection and treatment tracking for those at risk or diagnosed with ADRD.
Why it matters
Potential benefit: If successful, this research could lead to the development of affordable and non-invasive blood tests for early detection of Alzheimer's disease and related dementias.
How similar studies have gone: Previous research has shown promise in using blood-based biomarkers for Alzheimer's diagnosis, indicating that this approach could be a significant advancement in the field.
Where this research is happening
-
VA Boston Health Care System
Boston, United States Active
Researchers
- Principal investigator: Miller, Mark W — VA Boston Health Care System
- Study coordinator: Miller, Mark W
Related research
Other NIH-funded projects on the same topics.
-
Investigating how DNA damage and repair mechanisms are altered in ALS and frontotemporal dementia.
This study is looking at how problems with DNA repair might contribute to conditions like ALS and frontotemporal dementia, and it’s testing ways to fix these issues in cells from patients to help develop new treatments.
-
Synthetic protein mimetics to treat Lewy Body Dementia
A new therapeutic approach using engineered protein-like molecules to block the harmful protein clumps that cause Lewy Body Dementia.
-
Dementia care staff study: adapting a US survey for use in many countries
A study is adapting and testing a survey for dementia care workers in the US, Brazil, Switzerland, and Ghana to help understand why workers stay in their jobs and how to improve care.
-
Dementia care staff study: adapting a survey for use in many countries
A multinational study will adapt and test a U.S. dementia-care worker survey in Brazil, Switzerland, and Ghana to help understand why staff stay in or leave long-term care settings.
-
Study of Dementia Care Staff in 4 Countries: Adapting Caregiver Surveys Across Cultures
A multinational project will adapt and test a dementia care worker survey so researchers can compare care environments across the US, Brazil, Switzerland, and Ghana.
-
New biomarkers to distinguish LATE from Alzheimer’s disease in dementia
A study to develop blood and CSF tests that can tell apart LATE from Alzheimer’s disease in people with dementia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.